SCHEMBL25580888

SCHEMBL25580888

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2cccc(N(c3ccc(-c4ccc5ccccc5c4)cc3)c3ccc4c(c3)oc3ccccc34)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ ANO1 Q5XXA6 1/20 0.32
▸ MMP12 P39900 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ HSD17B1 P14061 2/20 0.32
▸ HSD17B2 P37059 2/20 0.32
▸ PLA2G2A P14555 2/20 0.31
▸ PLA2G4A P47712 2/20 0.31
▸ PGR P06401 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ PRKDC P78527 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ AHR P35869 1/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580749 0.98 HCRTR1 (0.35) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL25581019 0.98 HCRTR1 (0.35) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL25580601 0.97 HCRTR1 (0.34) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL23179249 0.95 HCRTR1 (0.36) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL24841788 0.95 HCRTR1 (0.36) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL25580885 0.94 ANO1 (0.34) HCRTR1GPR84ALOX5ANO1HSD17B1
SCHEMBL25580935 0.94 AHR (0.33) HCRTR1GPR84ALOX5PRKDCALDH1A1
SCHEMBL23179397 0.93 HCRTR1 (0.38) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL23180843 0.93 HCRTR1 (0.38) HCRTR1GPR84ALOX5ANO1MMP12
SCHEMBL25580653 0.93 AHR (0.34) HCRTR1GPR84ALOX5PRKDCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 HCRTR1 3385/4885GPR84 2791/4885ALOX5 1615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback